Given the following molecule represented by the SMILES string: Cc1cc(=O)oc(C)c1C(=O)NCc1ccccc1, and the following genes: ABCB1,ABL1,ADRA1D,ADRA2B,ADRB2,CA12,CA2,CA9,CACNA1H,CDK2,CHRM1,CHRM3,CHRM4,CNR1,CYP1A2,CYP2C19,CYP2C9,CYP2D6,CYP3A4,DRD2,DRD3,DRD4,EGFR,ESR1,FLT1,HRH1,HTR1A,HTR2A,HTR2B,HTR2C,HTR6,KCNH2,KDR,LCK,MCL1,OPRK1,PPARG,PTGS1,SIGMAR1,SLC6A2,SLC6A4, describe whether the molecule is related to one or a few of these genes in clear, simple and accurate English. Explain the relationship between the molecule and the related genes in detail. You can break down by explain the patterns of the molecule, followed by the gene features. Format the output as 'Step 1:', 'Step 2:', etc., with each step focusing on a specific aspect of the molecule's structure or properties. Finally, summarize the related gene names in a list. Limit the reasoning to at most 5 steps. You can stop after summarizing the related gene names. Step 1: The molecule has a complex structure featuring multiple rings, including an imidazole ring and a benzene ring, which are characteristic of many drug-like molecules. It also contains a pyridine ring and a carboxamide group, which are common in ligands for various receptors and enzymes.
Step 2: Given the presence of a carboxamide group (-CONH2), this molecule likely interacts with proteins that have carboxylate binding sites, such as ion channels, receptors, or enzymes. This functional group is known to be involved in forming hydrogen bonds and can participate in various binding modes, including catalysis and allosteric modulation.
Step 3: The presence of aromatic rings (benzene and pyridine) suggests potential interactions with aromatic amino acids in protein binding sites, which can stabilize the binding through pi-pi stacking or hydrophobic interactions. This is particularly relevant for G-protein coupled receptors (GPCRs) and ion channels.
Step 4: Considering the molecular structure, this compound could interact with several genes that encode proteins involved in neurotransmission, hormone signaling, and inflammatory responses. For example, it might interact with GPCRs like HTR2A (serotonin receptor 2A), HRH1 (histamine receptor H1), and DRD2 (dopamine receptor D2). It could also potentially interact with enzymes involved in metabolism such as CYP2C9 and CYP2D6.
Step 5: Based on the structural analysis, the molecule is most likely related to the following genes: ADRA1D, ADRA2B, ABL1, CYP2C9, CYP2D6, HTR1A, HTR2A, HRH1, DRD2, PTGS1, and CYP3A4. These genes encode proteins that may directly interact with the molecule or be influenced by its activity. 
Summary of related genes: ADRA1D, ADRA2B, ABL1, CYP2C9, CYP2D6, HTR1A, HTR2A, HRH1, DRD2, PTGS1, CYP3A4. 
Note: The exact interaction mechanism would require further experimental validation, but the described structure-function relationship provides a basis for understanding potential interactions. The listed genes represent those most likely to be involved based on the molecule's structure. Other genes could also be relevant depending on the specific biological context and the detailed pharmacological profile of the molecule. Step 1: The molecule has a complex structure featuring multiple rings, including an imidazole ring and a benzene ring, which are characteristic of many drug-like molecules.
- Related Genes: ABL1, CYP2C9, CYP2D6, CYP3A4
Step 2: Given the presence of a carboxamide group (-CONH2), this molecule likely interacts with proteins that have carboxylate binding sites, such as ion channels, receptors, or enzymes.
- Related Genes: HTR1A, HTR2A, HTR2B, HTR2C, HTR6, DRD2, DRD3, DRD4
Step 3: The presence of aromatic rings (benzene and pyridine) suggests potential interactions with aromatic amino acids in protein binding sites, which can stabilize the binding through pi-pi
